The Philippines: Accession to the Madrid Protocol is valid

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

The Philippines: Accession to the Madrid Protocol is valid

On July 19 2016, the Supreme Court (SC), in GR 204605, entitled Intellectual Property Association of the Philippines (IPAP) v Hon. Paquito Ochoa, in his capacity as Executive Secretary, et al, ruled that the Madrid Protocol is an executive agreement and that its ratification by President Aquino is valid and constitutional.

The IPAP, an association of IP law practitioners, filed the action seeking to declare the accession of the Philippines to the Madrid Protocol unconstitutional on the ground of lack of concurrence by the Senate, and because it conflicts with Section 125 of RA 8293 (the IP Code), on the necessity of appointing a resident agent to represent a foreign trade mark applicant.

The SC distinguished between treaties and international agreements which require the Senate's concurrence, and executive agreements which may be validly entered into without the Senate's concurrence. The SC noted that agreements with respect to the registration of trade marks have been concluded by the executive with various countries without the Senate's concurrence. Citing the declaration of state policy with respect to intellectual property as stated in the IP Code, the SC held that the IPAP was mistaken in asserting that there was no congressional act that authorised accession of the Philippines to the Madrid Protocol.

The SC also held that there was no conflict between the Madrid Protocol and the IP Code. The method of registration through the Intellectual Property Office of the Philippines (IPOPHL) as expressly stated in the IP Code is distinct and separate from the method of registration through the WIPO. The IPOPHL requires the designation of a resident agent when it refuses the registration of a mark, and when filing the declaration of actual use.

The Madrid Protocol does not amend nor modify the IP Code since trade mark applications filed through the Madrid Protocol are examined under the provisions of the IP Code. The SC further held that IPAP misapprehends the procedure for examination under the Madrid Protocol, and that the difficulty claimed by IPAP is minimal or inexistent. Hence the SC dismissed the IPAP petition for lack of merit.

Hechanova_Editha-100

Editha R Hechanova


Hechanova & Co., Inc.Salustiana D. Ty Tower104 Paseo de Roxas AvenueMakati City 1229, PhilippinesTel: (63) 2 812-6561Fax: (63) 2 888-4290

editharh@hechanova.com.ph  

www.hechanova.com.ph

more from across site and SHARED ros bottom lb

More from across our site

Our 2026 rankings for Western Europe, taken with historical data, reveal that some European IP markets hardly change – while others are more fluid
Selina Hinchliffe, head of commercial services at Shakespeare Martineau, reflects on rejecting Cambridge, leading through empathy, and why authenticity matters more than fitting in
US corporates are using the UPC, but much of that work still flows to European boutiques. Last week’s merger, as well as others, could alter that dynamic
Publicly listed Australian group IPH delivered on its promise to profoundly shake up the Canadian market. Four years on, rivals have had time to adapt
IP practitioners debate whether new guidelines will make it more difficult to challenge a patent
Varuni Paranavitane says she is excited to bring ‘rounded expertise’ to the firm, which will have a solicitor in its ranks for the first time
Lawyers adapting to AI-driven recommendations are being pushed to demonstrate expertise publicly rather than simply relying on a polished website
Mid-market businesses looking to establish an online presence need ‘holistic’ brand protection services at an accessible cost, according to partners
Our latest update also includes the latest case filing statistics, and an update on how a transatlantic merger could be a UPC opportunity for the US half of the partnership
New partners, from biotech company Leyden Labs and Novartis, take the total number of partner hires to 12 since the firm took on external investment in late 2024
Gift this article